FR2318649A1 - Treatment for rheumatism and cancer - contg. iodine, iodide, thiosulphate, polyvinyl pyrrolidone, an analgesic and an anaesthetic - Google Patents
Treatment for rheumatism and cancer - contg. iodine, iodide, thiosulphate, polyvinyl pyrrolidone, an analgesic and an anaestheticInfo
- Publication number
- FR2318649A1 FR2318649A1 FR7524444A FR7524444A FR2318649A1 FR 2318649 A1 FR2318649 A1 FR 2318649A1 FR 7524444 A FR7524444 A FR 7524444A FR 7524444 A FR7524444 A FR 7524444A FR 2318649 A1 FR2318649 A1 FR 2318649A1
- Authority
- FR
- France
- Prior art keywords
- soln
- iodine
- thiosulphate
- rheumatism
- analgesic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 title abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 title abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 title abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 title abstract 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 title abstract 2
- 230000003444 anaesthetic effect Effects 0.000 title 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 title 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Inorganic materials [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 159000000011 group IA salts Chemical class 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 abstract 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000003058 plasma substitute Substances 0.000 abstract 1
- 229960002901 sodium glycerophosphate Drugs 0.000 abstract 1
- 235000009518 sodium iodide Nutrition 0.000 abstract 1
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Medicaments contg. bisublimed iodine, sodium or potassium iodide, an alkaline salt, a plasma substitute, an analgesic, anti-inflammatory and antipyretic, and an anaesthetising agent are used for the treatment of rheumatism and cancer. A typical compsn. contains 0.10g iodine and 0.20 g KI dissolved in 2 ml. water, (soln A) 0.266g Mg thiosulphate in 2 ml water (soln B), 5 ml 25% polyvinyl pyrrolidone (soln C), 0.5 g acetylsalicylic and 0.85g sodium glycerophosphate in 5 ml water (soln D) and 0.05g diethyl amino 2,6-dimethyl acetanilide hydrochloride, 5 mg methyl p-hydroxy benzoate and an excipient to 5 ml (soln E). Solns. A and B were mixed together until decolorised and solns. C,D and E added.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7524444A FR2318649A1 (en) | 1975-07-22 | 1975-07-22 | Treatment for rheumatism and cancer - contg. iodine, iodide, thiosulphate, polyvinyl pyrrolidone, an analgesic and an anaesthetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7524444A FR2318649A1 (en) | 1975-07-22 | 1975-07-22 | Treatment for rheumatism and cancer - contg. iodine, iodide, thiosulphate, polyvinyl pyrrolidone, an analgesic and an anaesthetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2318649A1 true FR2318649A1 (en) | 1977-02-18 |
| FR2318649B1 FR2318649B1 (en) | 1980-04-04 |
Family
ID=9158795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7524444A Granted FR2318649A1 (en) | 1975-07-22 | 1975-07-22 | Treatment for rheumatism and cancer - contg. iodine, iodide, thiosulphate, polyvinyl pyrrolidone, an analgesic and an anaesthetic |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2318649A1 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558062A1 (en) * | 1984-01-17 | 1985-07-19 | Morgan George | Medicinal preparation which can be administered orally, for the treatment of cold and/or influenza. |
| US4590183A (en) * | 1985-04-22 | 1986-05-20 | Sterling Drug Inc. | Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin |
| US4816255A (en) * | 1985-07-31 | 1989-03-28 | Ghent William R | Treatment of iodine deficiency breast syndrome |
| US5250304A (en) * | 1985-07-31 | 1993-10-05 | Ghent William R | Treatment of iodine deficiency diseases |
| US5910318A (en) * | 1991-03-28 | 1999-06-08 | 943038 Ontario Inc. | Treatment of iodine deficiency diseases |
| US5955101A (en) * | 1991-03-28 | 1999-09-21 | 943038 Ontario Inc. | Dry starch-iodine pharmaceutical formulations |
| US6019970A (en) * | 1985-07-31 | 2000-02-01 | Ghent William R. | Treatment of iodine deficiency diseases |
-
1975
- 1975-07-22 FR FR7524444A patent/FR2318649A1/en active Granted
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558062A1 (en) * | 1984-01-17 | 1985-07-19 | Morgan George | Medicinal preparation which can be administered orally, for the treatment of cold and/or influenza. |
| US4590183A (en) * | 1985-04-22 | 1986-05-20 | Sterling Drug Inc. | Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin |
| US4816255A (en) * | 1985-07-31 | 1989-03-28 | Ghent William R | Treatment of iodine deficiency breast syndrome |
| US5250304A (en) * | 1985-07-31 | 1993-10-05 | Ghent William R | Treatment of iodine deficiency diseases |
| US6019970A (en) * | 1985-07-31 | 2000-02-01 | Ghent William R. | Treatment of iodine deficiency diseases |
| US5910318A (en) * | 1991-03-28 | 1999-06-08 | 943038 Ontario Inc. | Treatment of iodine deficiency diseases |
| US5955101A (en) * | 1991-03-28 | 1999-09-21 | 943038 Ontario Inc. | Dry starch-iodine pharmaceutical formulations |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2318649B1 (en) | 1980-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA23170A1 (en) | PROCESS FOR THE PREPARATION OF A NEW COMPOUND. | |
| JPS51118839A (en) | Amino acid pharmacy for liverish patient dosage | |
| IT1128094B (en) | CATHETER FOR INTERMITTENT MEDICAMENT EN DOVENOUS ADMINISTRATION | |
| JPS5225013A (en) | Insulin pharmaceutical for nasal administration | |
| GR1001503B (en) | Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses. | |
| IS1858B (en) | Method of producing a pharmaceutical composition in the form of pellets for the treatment of intestinal inflammation | |
| SE8002322L (en) | Means for the treatment of inflammatory bowel diseases | |
| IE42950L (en) | X-ray contrast preparations | |
| FR2318649A1 (en) | Treatment for rheumatism and cancer - contg. iodine, iodide, thiosulphate, polyvinyl pyrrolidone, an analgesic and an anaesthetic | |
| TW349865B (en) | Therapeutic agent for hemorrhoidal diseases | |
| ES452987A1 (en) | Thiazolo{8 3,4-b{9 isoquinoline derivatives and pharmaceutical compositions containing them | |
| DK0583271T3 (en) | Aryl morpholine, manufacture and use | |
| ATE22879T1 (en) | PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR MANUFACTURE. | |
| FR2319346A1 (en) | MEDICINAL PRODUCT CONTAINING A COMBINATION OF ANTI-INFLAMMATORY AGENT AND IMIDAZOLE OR BENZIMIDAZOLE | |
| IL97855A0 (en) | Bromide containing pharmaceutical compositions for treatment of psoriasis | |
| FR2417494A1 (en) | Sodium paracetamol hemi:succinate - is very soluble in water and without unpleasant taste of paracetamol | |
| HUT35519A (en) | Process for producing of anelgetic medical preparatives | |
| JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
| JPS5788113A (en) | Rectum medication composition | |
| JPS5426325A (en) | Suppository | |
| DE3380294D1 (en) | Pharmaceutical compositions in oral dosage form | |
| JPS56122310A (en) | Suppository | |
| JPS56147715A (en) | Anticataractal agent | |
| JPS5218067A (en) | Contact lens cleaner | |
| FR2308368A1 (en) | Lysine salt of cephalexin - effect when administered parenterally as well as orally |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |